Candon D, Healy J, Crown J. Modelling the cost-effectiveness of adjuvant lapatinib for early-stage breast cancer. AO [Internet]. 2014 Feb. 1 [cited 2026 May 12];53(2):201-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26987